$CXM

Rory P. Read plans $809K Sprinklr (CXM) stock sale

Sprinklr (CXM) insider Rory P. Read plans to sell 145,865 shares, valued at approximately $809,550. The shares are part of restricted stock vesting under a registered plan, with Morgan Stanley Smith Barney LLC as the broker. Read previously sold 143,654 shares in the last three months for around $761,050.

Original reporting
Published Sep 16, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 4:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CXM
Neutral
medium confidence
Mentioned
$CXM
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CXMNeutralLow
01

Why it matters

The disclosed sale represents a modest amount of shares relative to total outstanding shares, likely causing minimal market impact.

02

Market read

Primary relevance is to Sprinklr shareholders; broader market impact is negligible.

03

What to watch

Potential upcoming earnings or product news could amplify the impact of the sale.

Relevance 4/10Novelty 3/10Timing: reported today

Background

Form 144 filings are required for insiders selling restricted stock; they provide transparency on upcoming sales.

Company-level read

Ticker impact

$CXMNeutralMedium confidence
Context

Form 144 filing shows insider Rory P. Read plans to sell 145,865 shares (~$809K) of Sprinklr.

Expected impact

Limited downside risk; likely negligible price movement.

Evidence & confidence

Sale size is modest relative to market cap and typical insider transactions; no broader implications.

Market effects

None significant for the broader SaaS sector.

No regional effect.

Limited to Sprinklr shareholders.

Counterpoint

Insider sale could be interpreted as lack of confidence, but may simply be liquidity need.

Key entities

  • Rory P. Read

    Executive/insider of Sprinklr planning the stock sale.

  • Sprinklr, Inc.

    Provider of customer experience management software, ticker CXM.

Related articles

$CXMMed

Sprinklr Earnings Call: AI Momentum Amid Services Drag

Sprinklr (CXM) reported Q2 revenue of $213.7M, up 1% YoY, with subscription revenue growing 3%. Non-GAAP net income was $0.11 per share. Management highlighted strong enterprise deal flow, AI growth, and a record $1.03B in contracted revenue. However, professional services underperformed, with negative gross margins. The company completed a $125M share repurchase program and has $75M remaining under its authorization.

$CXMMedAI 8/10

Sprinklr (CXM) Q2 2027 Earnings Call Transcript

Sprinklr (CXM) reported Q2 2027 revenue of $213.7M, up 1% YoY, with subscription revenue growing 3% YoY. Professional services revenue declined 20% YoY. Non-GAAP operating income was $31.3M, with a 15% margin. Total RPO grew 11% YoY to $1.03B. Q3 revenue guidance is $215M-$216M, with subscription revenue projected at $196M-$197M. CEO Rory Read will lead services organization interim to improve performance. The company added Tom Addis as CRO and Jordi Ribas to its board.

Med

Sprinklr, Inc. Q2 2027 Earnings Call Summary

Sprinklr reported Q2 2027 earnings, highlighting a 30% year-over-year increase in sales transactions and improved renewal rates. The company is transitioning to a unified AI-native platform strategy, with AI investments and weekly innovation cycles. Professional services underperformed due to execution challenges, but management expects margin neutrality soon. Subscription revenue growth is projected to resume in Q3, with a conservative outlook for services. The company completed a $125 million

$CXMMed

Sprinklr’s (NYSE:CXM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Sprinklr (NYSE: CXM) reported Q2 CY2026 revenue of $213.7M, flat year-over-year and in line with estimates. The company expects Q3 revenue of $215.5M, slightly above analyst forecasts. Non-GAAP EPS of $0.11 met expectations. Management guided for a 1.6% YoY decline in Q3 sales. Analysts project flat revenue growth over the next 12 months. The stock fell 2.2% post-earnings to $7.43.